English
Home > Products > 202825-46-5

China 202825-46-5 Factory

We always believe that one's character decides products' quality, the details decides products' quality ,with the REALISTIC,EFFICIENT AND INNOVATIVE team spirit for 202825-46-5,CAS NO 202825-46-5,Safinamide API,Safinamide mesylate, We are generally looking ahead to forming effective business associations with new clientele around the world.
202825-46-5, We hope to have long-term cooperation relationships with our clients. If you are interested in any of our items, be sure to do not hesitate to send enquiry to us/company name. We ensure that you can be totally satisfied with our best solutions!

Related Products

Hot Products

  • Tetrabutylammonium fluoride

    Tetrabutylammonium fluoride

    Product Name:Tetrabutylammonium fluoride
    Molecular Formula:C16H36FN
    Molecular Weight:261.46
    CAS Registry Number:429-41-4
  • Givosiran

    Givosiran

    Product Name:Givosiran
    Molecular Formula:C78H139N11O30
    Molecular Weight;1710.994
    CAS Registry Number;1639325-43-1
  • 3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazole

    3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazole

    Product Name:3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazole
    Molecular Formula:C10H5F6N3
    Molecular Weight:281.16
    CAS Registry Number:1333154-10-1
  • 4-Formylphenylboronic acid

    4-Formylphenylboronic acid

    Product Name:4-Formylphenylboronic acid
    Molecular Formula:C7H7BO3
    Molecular Weight:149.94
    CAS Registry Number:87199-17-5
  • 5-Bromo-2-Methyl Benzoic Acid

    5-Bromo-2-Methyl Benzoic Acid

    5-Bromo-2-Methyl Benzoic Acid
    Molecular Formula: C8H7BrO2
    Formula Weight: 215.04
    CAS NO:79669-49-1
    Usage:Canagliflozin Intermediates​
  • Crisaborole

    Crisaborole

    Product Name:Crisaborole
    Molecular Formula:C14H10BNO3
    Molecular Weight;251.05
    CAS Registry Number;906673-24-3
  • Related Blog
  • Reviews

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Related Search

CAS NO 202825-46-5

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept